LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,705,992 | -17.7% | 61,849 | -0.9% | 0.46% | -15.4% |
| Q2 2023 | $4,501,636 | -6.1% | 62,436 | -4.2% | 0.54% | -6.5% |
| Q1 2023 | $4,793,390 | +9.8% | 65,163 | -0.3% | 0.58% | +9.2% |
| Q4 2022 | $4,366,850 | -40.9% | 65,372 | -23.9% | 0.53% | -45.7% |
| Q3 2022 | $7,393,000 | -3.6% | 85,857 | -0.1% | 0.98% | +3.8% |
| Q2 2022 | $7,671,000 | -21.5% | 85,975 | -1.0% | 0.95% | -6.7% |
| Q1 2022 | $9,768,000 | -27.6% | 86,834 | -0.6% | 1.02% | -24.4% |
| Q4 2021 | $13,499,000 | +2.6% | 87,392 | -7.5% | 1.34% | +1.5% |
| Q3 2021 | $13,158,000 | +1.9% | 94,443 | -4.0% | 1.32% | +15.9% |
| Q2 2021 | $12,908,000 | -16.9% | 98,388 | -3.4% | 1.14% | -9.5% |
| Q1 2021 | $15,535,000 | +60.1% | 101,899 | +4.5% | 1.26% | +41.2% |
| Q4 2020 | $9,701,000 | +38.0% | 97,542 | +32.3% | 0.89% | +11.5% |
| Q3 2020 | $7,028,000 | – | 73,729 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |